[1] Outlioua A, Pourcelot M, Aroult D.The role of optineurin in antiviral type I interferon production[J]. Front Immunol, 2018, 9:853. [2] Yang L, Xu I, Li Y, et al.Molecular and functional characterization of canine interferon-epsilon[J]. J Interferon Cytokine Res, 2013, 33:760-768. [3] Bertolotto A.Evaluation of the impact of neutralizing antibodies on IFNbeta response[J]. Clin Chim Acta, 2015, 449:31-36. [4] Spitzbarth I, Baumagartner W, Beineke A.The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine CNS diseases[J]. Vet Immunol Immunopathol, 2012, 147:6-24. [5] Huang B, Qi ZT, Xu Z, et al.Global characterization of interferon regulatory factor(IRF)genes in vetebrates:glimpse of the diversification in evolution[J]. BMC Immunol, 2010, 11:22. [6] Toledo Pinto TG, Batista-Silva LR, Medeiros RCA, et al.Type I interferons, sutophagy and host metabolism in Leprosy[J]. Front Immunol, 2018, 9:806. [7] Yarbrough ML, Zhang K, Sakthivel R, et al.Primate-specific miR-576-3p sets host defense signaling threshold[J]. Nat Commun, 2014, 5:4963. [8] Field AK, Tytell AA, Lampson GP, et al.Inducers of interferon and host resistance, V. In vitro studies[J]. Proc Natl Acad Sci USA, 1968, 61:340-346. [9] Smith JS, Yager PA, Baer GM, et al.Minimal interferon induction in dogs, using a modified polyriboinosinic-polyribocytidylic acid complex[J]. Am J Vet Res, 1980, 41:1833-1835. [10] Bridgman R, Rossi CR, Campos M.The sensitivity of domestic animal cell lines to eight recombinant human interferons[J]. J Interferon Res, 1988, 8:1-4. [11] Hu CJ, Ozes ON, Klein SB, et al.Comparison of the in vitro host range of recombinant met-interferon-con 1, interferon-alpha 2b, and interferon-beta[J]. J Interferon Cytokine Res, 1995, 15:231-234. [12] Zhang J, Yao Q, Liu Z.An effective synthesis method for tilorone dihydrocholoride with obvious IFN-alpha inducing activity[J]. Molecules, 2015, 20:21458-21463. [13] Bienias M, Bruck N, Griep C, et al.Therapeutic approaches to type I interferonopathies[J]. Curr Rheumatol Rep, 2018, 20:32. [14] Du CY, Zheng KY, Bi CW, et al.Yu Ping Feng San, an ancient Chinese herbal decoction, induces gene expression of anti-viral proteins and inhibits neuraminidase activity[J]. Phytohter Res, 2015, 29:656-661. [15] Krakowka S, Cummins JM, Ringler SS.The effects of human interferon-alpha upon in vitro canine immune responses[J]. Vet Immunol Immunopthol, 1988, 19:185-196. [16] Berger Rentsch M, Zimmer G.A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon[J]. PLoS One, 2011, 6(10):e25858. [17] Wang Y, Tian Q, Xu X, et al.Recombinant rabies virus expression IFNalpha 1 enhanced immune responses resulting in its attenuation and stronger immunogenicity[J]. Virology, 2014, 6:468-470. [18] Yang F, Pan Y, Chen Y, et al.Expression and purification of canis interferon alpha in Escherichia coli using different tags[J]. Protein Expr Purif, 2015, 115:76-82. [19] Yang L, Xu L, Li Y, et al.Molecular and functinal characterization of canine interferon-epsilon[J]. J Interferon Cytokine Res, 2013, 33:760-768. [20] Kotredes KP, Gamero AM.Interferons as inducers of apoptosis in malignant cells[J]. J Interferon Cytokine Res, 2013, 33:162-170. [21] Ivashkiv LB, Donlin LT.Regulation of type I interferon response[J]. Nat Rev Immunol, 2014, 14:36-49. [22] Lee S, Hirohama M, Noguchi M, et al. Influenza A virus infection triggers pyroptosis and apoptosis of respiratory epithelial cells through type I IFN signaling pathway in a mutually exclusive manner[J]. J Virol, 2018, pii:JVI. 00396-18. [23] Detje CN, Lienenklaus S, Chhatbar C, et al.Upon intranasal vesicular stomatitis virus infection, astrocytes in the olfactory bulb are important interferon beta producers that protect from lethal encephalitis[J]. J Virol, 2015, 89:2731-2738. [24] Busnadiego I, Kane M, Rihn SJ, et al.Host and viral determinants of Mx2 antitiretroviral activity[J]. J Virol, 2014, 88:7738-7752. [25] Haller O, Staeheli P, Schwemmle M, et al.Mx GTPases:dynamin-like antiviral machines of innate immunity[J]. Trends Microbiol, 2015, 23:154-163. [26] Ulrich R, Puff C, Wewetzer K, et al.Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis factor a biphasic mode of demyelination[J]. PLoS One, 2014, 9:e95917. [27] Ito A, Isogai E, Yoshiok K, et al.Ability of orally administered IFN-alpha4 to inhibit naturally occuring gingival inflammation in dogs[J]. J Vet Med Sci, 2010, 72:1145-1151. [28] Ban YH, Park SR, Yoon YJ.The biosynthetic pathway of FK506 and its engineering:from past achievements to future prospects[J]. J Ind Microbiol Biotechnol, 2016, 43:389-400. [29] Pfankuche VM, Spitzbarth I, Lapp S, et al.Reduced angiogenic gene expression in morbillivirus-triggered oncolysis in a translational model for histiocytic sarcoma[J]. J Cell Mol Med, 2017, 21:816-830. [30] Rossi UA, Gil-Gardeza ML, Villaverde MS, et al.Interferon-beta gene transfer induces a strong cytotoxic bystander effect on melanoma cells[J]. Biomed Pharmacother, 2015, 72:44-51. [31] Su S, Huang S, Fu C, et al.Identification of the IFN-beta response in H3N2 canine influenza virus infection[J]. J Gen Virol, 2016, 97:18-26. [32] Santoro D, Rodrigues Hoffmann A.Canine and human atopic dermatitis:two faces of the same host-microbe interaction[J]. J Invest Dermatol, 2016, 136:1087-1089. [33] Saridomichelakis MN, Olivry T.An update on the treatment of canine atopic dermatitis[J]. Vet J, 2016, 207:29-37. |